DMM, H., AR, B., PR, B., C, M., L, W., S, W., . . . K, A. (2026). Tryptophan pathway metabotypes associate with disease activity and immune-metabolic dysfunction in inflammatory bowel disease. MedRxiv : the preprint server for health sciences. https://doi.org/10.64898/2026.05.03.26352309
Chicago Style (17th ed.) CitationDMM, Harris, et al. "Tryptophan Pathway Metabotypes Associate with Disease Activity and Immune-metabolic Dysfunction in Inflammatory Bowel Disease." MedRxiv : The Preprint Server for Health Sciences 2026. https://doi.org/10.64898/2026.05.03.26352309.
MLA (9th ed.) CitationDMM, Harris, et al. "Tryptophan Pathway Metabotypes Associate with Disease Activity and Immune-metabolic Dysfunction in Inflammatory Bowel Disease." MedRxiv : The Preprint Server for Health Sciences, 2026, https://doi.org/10.64898/2026.05.03.26352309.